ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 237 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,350,000 | -61.3% | 41,611 | -66.7% | 0.35% | -47.6% |
| Q1 2016 | $3,490,000 | +375.5% | 124,853 | +505.6% | 0.67% | +546.6% |
| Q4 2015 | $734,000 | -85.3% | 20,615 | -86.6% | 0.10% | -76.9% |
| Q1 2015 | $5,009,000 | -42.1% | 153,717 | -43.6% | 0.44% | -42.5% |
| Q4 2014 | $8,647,000 | +8.9% | 272,350 | -15.1% | 0.77% | +5.2% |
| Q3 2014 | $7,943,000 | -16.4% | 320,821 | -23.7% | 0.74% | -4.4% |
| Q2 2014 | $9,497,000 | -7.9% | 420,411 | -0.9% | 0.77% | -2.5% |
| Q1 2014 | $10,316,000 | -51.1% | 424,032 | -49.8% | 0.79% | -44.8% |
| Q4 2013 | $21,087,000 | -16.6% | 843,851 | -8.3% | 1.43% | -12.6% |
| Q3 2013 | $25,272,000 | +47.4% | 920,017 | -2.6% | 1.64% | +19.8% |
| Q2 2013 | $17,150,000 | – | 944,930 | – | 1.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |